SEARCH
Search Details
Kawayama Tomotaka
Division of Respirology Neurology and Rheumatology Department of Internal Medicine
Professor
Research activity information
■ Paper
■ Affiliated academic society
■ 共同研究実績
■ 関心を持って取組んでいる活動
- Eosinophilic Meningoencephalitis Occurred during Oral Corticosteroid Tapering and after Switching from Anti-IL-5 to Anti-IgE Treatment
Yuuya Nishii; Takashi Kinoshita; Jun Sasaki; Shingo Tsuneyoshi; Kenichi Irie; Takahisa Tateishi; Masaki Tominaga; Takayuki Taniwaki; Tomoaki Hoshino; Tomotaka Kawayama
Internal Medicine, 01 Jan. 2025 - Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history
Shigeo Muro; Tomotaka Kawayama; Hisatoshi Sugiura; Munehiro Seki; Elizabeth A. Duncan; Karin Bowen; Jonathan Marshall; Ayman Megally; Mehul Patel
Respiratory Research, 05 Aug. 2024 - AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD
Klaus F. Rabe; Fernando J. Martinez; Surya P. Bhatt; Tomotaka Kawayama; Borja G. Cosio; Robert M. Mroz; Maarten M. Boomsma; Helene Goulaouic; Michael C. Nivens; Michel Djandji; Xavier Soler; Ying Liu; Matthew P. Kosloski; Christine R. Xu; Nikhil Amin; Heribert Staudinger; David J. Lederer; Raolat M. Abdulai
ERJ Open Research, 09 May 2024 - STAT1 Mutations in Chronic Mucocutaneous Candidiasis Diagnosed in an Adult
Miya Andou; Masaki Tominaga; Ryuta Nishikomori; Kenji Gotoh; Nobukazu Komatsu; Masanobu Matsuoka; Tomotaka Kawayama; Tomoaki Hoshino
Internal Medicine, 01 May 2024 - Altered Functional Connectivity during Mild Transient Respiratory Impairment Induced by a Resistive Load
Akiko Yorita; Tomotaka Kawayama; Masayuki Inoue; Takashi Kinoshita; Hanako Oda; Yoshihisa Tokunaga; Takahisa Tateishi; Yoshihisa Shoji; Naohisa Uchimura; Toshi Abe; Tomoaki Hoshino; Takayuki Taniwaki
Journal of Clinical Medicine, 26 Apr. 2024 - Examination of prognostic factors in anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis
Suzuna Sugi; Masaki Tominaga; Shinjiro Kaieda; Kiminori Fujimoto; Tomonori Chikasue; Takuma Koga; Yuri Hasuo; Erina Iwanaga; Kenta Murotani; Jamie Kristen T Lim; Hiroaki Ida; Tomotaka Kawayama; Tomoaki Hoshino
Modern Rheumatology, 01 Feb. 2024 - Endobronchial cryptococcosis with bronchial stenosis in a patient with severe asthma treated with inhaled corticosteroids: A case report
Jun Sasaki; Takashi Kinoshita; Misa Sudou; Takayuki Horii; Reiko Takaki; Masahiro Mitsuoka; Masaki Tominaga; Tomotaka Kawayama; Tomoaki Hoshino
Respirology Case Reports, 17 Nov. 2023 - Management goals and stable phase management of patients with chronic obstructive pulmonary disease in the Japanese respiratory society guideline for the management of chronic obstructive pulmonary disease 2022 (6th edition)
Shibata Y, Kawayama T, Muro S, Sugiura H; members of Japanese Respiratory Society COPD Guideline 6th Edition Editing Committee.
Respir Investig, Nov. 2023 - Combination of Prednisolone and Calcineurin Inhibitors Prevents Lung Function Decline in Patients with Anti-aminoacyl-tRNA Synthetase Antibody-Positive Polymyositis/Dermatomyositis.
Yorishima Y, Tominaga M, Fujimoto K, Nagata S, Sumi A, Chikasue T, Okamoto M, Kaieda S, Matama G, Zaizen Y, Obara H, Kakuma T, Ida H, Kawayama T, Hoshino T.
Kurume Med J, Nov. 2023 - Exacerbation rates in Japanese patients with obstructive lung disease: A subanalysis of the prospective, observational NOVELTY study
Kawayama T, Takahashi K, Ikeda T, Fukui K, Makita N, Tashiro N, Saito J, Shirai T, Inoue H.
Allergol Int, Sep. 2023 - Yorita A, Tokunaga Y, Kinoshita T, Nakakura A, Oda H, Imaoka H, Matsunaga K, Kakuma T, Hoshino T, Kawayama T.
Yorita A, Tokunaga Y, Kinoshita T, Nakakura A, Oda H, Imaoka H, Matsunaga K, Kakuma T, Hoshino T, Kawayama T.
Kurume Med J, Sep. 2023 - Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE)
Ichikado K, Kotani T, Kondoh Y, Imanaka H, Johkoh T, Fujimoto K, Nunomiya S, Kawayama T, Sawada M, Jenkins E, Tasaka S, Hashimoto S
Stem Cell Res Ther, Aug. 2023 - Efficacy and safety of once-daily single-inhaler triple therapy for mild-to-moderate chronic obstructive pulmonary disease: a study protocol for a randomised and interventional study.
Takahashi K, Kawayama T, Takamori A, Tashiro H, Kinoshita T, Takagi K, Yamasaki K, Machida K, Kawaguchi A, Yatera K, Inoue H; TRACK (Triple therapy for Japanese with mild to moderate COPD in Kyushu) study investigator group.
BMJ Open Respir Res, May 2023 - The Efficacy and Safety of First-Line Single-Inhaler Triple versus Dual Therapy in Controller-Na?ve and Symptomatic Adults with Asthma: A Preliminary Retrospective Cohort Study
Fujiki R, Kawayama T, Furukawa K, Kinoshita T, Matsunaga K, Hoshino T
J Asthma Allergy, Feb. 2023 - The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis
Tanimura K, Sato S, Fujita Y, Yamamoto Y, Hajiro T, Horita N, Kawayama T, Muro S
Chron Respir Dis, Jan. 2023 - LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations
Miravitlles M, Kawayama T, Dreher M.
J Clin Med, Nov. 2022 - Daytime and Nighttime Visual Analog Scales May Be Useful in Assessing Asthma Control Levels Before and After Treatment.
Fujiki R, Kawayama T, Furukawa K, Kinoshita T, Matsunaga K, Hoshino T.
J Asthma Allergy, Oct. 2022 - Poor Asthma Control in Schoolchildren May Lead to Lower Lung Function Trajectory from Childhood to Early Adulthood: A Japanese Cohort Study
Tsuneyoshi S, Kawayama T, Sasaki J, Kinoshita T, Yano C, Tokunaga Y, Matsuoka M, Imaoka H, Matsunaga K, Furukawa K, Hoshino T
J Asthma Allergy, Jun. 2022 - Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy.
Harada Y, Tominaga M, Iitoh E, Kaieda S, Koga T, Fujimoto K, Chikasue T, Obara H, Kakuma T, Ida H, Kawayama T, Hoshino T
J Clin Med, Mar. 2022 - Airway hyperresponsiveness and inflammation in Japanese patients with human immunodeficiency virus 1 infection
Yano C, Tominaga M, Naito Y, Tokunaga Y, Kinoshita T, Sasaki J, Okamoto M, Yaita K, Obara H, Kakuma T, Hoshino T, Kawayama T
J Infect Chemother, Mar. 2022 - Triple versus LAMA/LABA combination therapy for Japanese patients with COPD: A systematic review and meta-analysis
Koarai A, Yamada M, Ichikawa T, Fujino N, Kawayama T, Sugiura H
Respir Investig, Jan. 2022 - Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Na?ve Chronic Obstructive Pulmonary Disease
Takahashi K, Tashiro H, Tajiri R, Takamori A, Uchida M, Kato G, Kurihara Y, Sadamatsu H, Kinoshita T, Yoshida M, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-na?ve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group
Int J Chron Obstruct Pulmon Dis., Dec. 2021 - Successful treatment of idiopathic tracheobronchial inflammatory polyposis using endoscopic argon plasma coagulation: a case report.
Inoue Y, Imamura Y, Murakami D, Tanikawa K, Kamimura T, Kinoshita T, Nishiyama M, Kawayama T
Med Case Rep Study Protoc, Mar. 2021 - Overweight improves long-term survival in Japanese patients with asthma
Yano C, Kawayama T, Kinoshita T, Tokunaga Y, Sasaki J, Sakazaki Y, Matsuoka M, Imaoka H, Nishiyama M, Matsunaga K, Furukawa K, Hoshino T
Allergol Int, Feb. 2021 - Triple versus LAMA/LABA combination therapy for patients with COPD: a systematic review and meta-analysis
Koarai A, Yamada M, Ichikawa T, Fujino N, Kawayama T, Sugiura H
Respir Res, Jan. 2021 - Fulminant Tracheobronchial Aspergillosis in an Apparently Healthy Adult
Moribuchi H, Sato R, Matsushima S, Tominaga M, Sasaki J, Nakamura M, Sakazaki Y, Nishiyama M, Hoshino T, Kawayama T
Intern Med, Oct. 2020 - Using fractional exhaled nitric oxide to guide step-down treatment decisions in patients with asthma: a systematic review and individual patient data meta-analysis
Wang K, Verbakel JY, Oke J, Fleming-Nouri A, Brewin J, Roberts N, Harada N, Atsuta R, Takahashi K, Mori K, Fujisawa T, Shirai T, Kawayama T, Inoue H, Lazarus S, Szefler S, Martinez F, Shaw D, Pavord ID, Thomas M
Eur Respir J, May 2020 - First-Line Treatment with Tiotropium/Olodaterol Improves Physical Activity in Patients with Treatment-Na?ve Chronic Obstructive Pulmonary Disease
3. Takahashi K, Uchida M, Kato G, Takamori A, Kinoshita T, Yoshida M, Tajiri R, Kojima K, Inoue H, Kobayashi H, Sadamatsu H, Tashiro H, Tanaka M, Hayashi S, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-na?ve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group
Int J Chron Obstruct Pulmon Dis, 2020 - Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis
Koarai A, Sugiura H, Yamada M, Ichikawa T, Fujino N, Kawayama T, Ichinose M.
BMC Pulm Med, Jan. 2020 - Impact of airflow obstruction on long-term mortality in patients with asthma in Japan
Okayama Y, Kawayama T, Kinoshita T, Tokunaga Y, Sasaki J, Sakazaki Y, Imaoka H, Hoshino T
Allergol Int, Apr. 2019 - Differences in Adherence Barriers to Inhaled Medicines between Japanese Patients with Chronic Obstructive Pulmonary Disease and Asthma Evaluated using the "Adherence Starts with Knowledge 20" (ASK-20) Questionnaire.
Takayuki Toyama; Tomotaka Kawayama; Takashi Kinoshita; Yohei Imamura; Makoto Yoshida; Koichiro Takahashi; Kazuhiko Fujii; Ikkou Higashimoto; Tomoaki Hoshino
Internal medicine (Tokyo, Japan), 15 Jan. 2019, [Reviewed] - Imidafenacin, An Orally Active Muscarinic Receptor Antagonist, Improves Pulmonary Function In Patients With Chronic Obstructive Pulmonary Disease: A Multicenter, Randomized, Double-Blind, Placebo-Controlled 3×3 Crossover Phase II Trial
Machida K, Kawayama T, Kinoshita M, Ichinose M, Tsuda T, Takata S, Koto H, Yoshida M, Ashihara Y, Kawashima M, Suna H, Inoue H
Int J Chron Obstruct Pulmon Dis, 2019 - Successful Treatment of Rapidly Progressive Unclassifiable Idiopathic Interstitial Pneumonia with Anti-melanoma Differentiation-associated Gene-5 Antibody by Intensive Immunosuppressive Therapy
Koga T, Kaieda S, Okamoto M, Masuda K, Fujimoto K, Sakamoto S, Nakamura M, Tominaga M, Kawayama T, Fujimoto K, Hoshino T, Ida H
Intern Med, Jul. 2018 - Role of Regulatory T cells in Airway Inflammation in Asthma
Kawayama T, Kinoshita T, Matsunaga K, Naito Y, Sasaki J, Tominaga Y, Hoshino T
Kurume Med J, Mar. 2018 - High Detection Rates of Urine Mycobacterium tuberculosis in Patients with Suspected Miliary Tuberculosis
Yokoyama T, Kinoshita T, Okamoto M, Matsunaga K, Kamimura T, Kinoshita M, Rikimaru T, Taguchi K, Hoshino T, Kawayama T
Intern Med., Aug. 2017 - How do we critically use long-acting muscarinic receptor antagonists and beta-adrenergic receptor agonists monotherapy, or these combination therapies depending on the situation in Japanese patients with COPD?
Kawayama T, Sasaki J
Respir Investig, Jun. 2017 - Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis
Tominaga M, Okamoto M, Kawayama T, Matsuoka M, Kaieda S, Sakazaki Y, Kinoshita T, Mori D, Inoue A, Hoshino T.
Respir Investig, May 2017 - Poor pharmacological adherence to inhaled medicines compared with oral medicines in Japanese patients with asthma and chronic obstructive pulmonary disease
Imamura Y, Kawayama T, Kinoshita T, Sakazaki Y, Yoshida M, Takahashi K, Fujii K, Ando M, Hoshino T, Iwanaga T, Kohrogi H; Kyushu Asthma Seminar Investigators
Allergol Int, Mar. 2017 - Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.
Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T
Respir Investig, Jan. 2017 - Dental Technicians' Pneumoconiosis
Okamoto M, Tominaga M, Shimizu S, Yano C, Masuda K, Nakamura M, Zaizen Y, Nouno T, Sakamoto S, Yokoyama M, Kawayama T, Hoshino T
Intern Med, 2017 - A case of lipoid pneumonia caused by inhalation of vaporized paraffin from burning candles
Katsumi H, Tominaga M, Tajiri M, Shimizu S, Sakazaki Y, Kinoshita T, Okamoto M, Kawayama T
Respir Med Case Rep, Oct. 2016 - A retrospective cohort study of outcome in systemic sclerosis-associated interstitial lung disease.
Okamoto M, Fujimoto K, Sadohara J, Furuya K, Kaieda S, Miyamura T, Suematsu E, Kitasato Y, Kawayama T, Ida H, Ichiki M, Hoshino T
Respir Investig, Jun. 2016 - Responsiveness of blood and sputum inflammatory cells in Japanese COPD patients, non-COPD smoking controls, and non-COPD nonsmoking controls.
Kawayama T, Kinoshita T, Matsunaga K, Kobayashi A, Hayamizu T, Johnson M, Hoshino T.
Int J Chron Obstruct Pulmon Dis, Feb. 2016 - "Frequent exacerbator" is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease.
Tomioka R, Kawayama T, Suetomo M, Kinoshita T, Tokunaga Y, Imaoka H, Matsunaga K, Okamoto M, Hoshino T.
Int J Chron Obstruct Pulmon Dis, Feb. 2016 - Evaluation of the Modified Medical Research Council Dyspnea Scale for Predicting Hospitalization and Exacerbation in Japanese Patients with Chronic Obstructive Pulmonary Disease.
Natori H, Kawayama T, Suetomo M, Kinoshita T, Matsuoka M, Matsunaga K, Okamoto M, Hoshino T.
Intern Med, Jan. 2016 - Chronic rhinosinusitis is associated with airflow obstruction in Japanese never-smokers without asthma.
Matsumoto K, Kawayama T, Kinoshita T, Minami S, Matsunaga K, Nagafuchi M, Hoshino T, Rikimaru T:
Int J Respir Pulm Med, Jul. 2015 - Serum level of periostin can predict long-term outcome of idiopathic pulmonary fibrosis.
Tajiri M, Okamoto M, Fujimoto K, Johkoh T, Ono J, Tominaga M, Azuma K, Kawayama T, Ohta S, Izuhara K, Hoshino T.
Respir Investig, Apr. 2015 - Paired maximum inspiratory and expiratory plain chest radiographs for assessment of airflow limitation in chronic obstructive pulmonary disease.
Kinoshita T, Kawayama T, Imamura Y, Sakazaki Y, Hirai R, Ishii H, Suetomo M, Matsunaga K, Azuma K, Fujimoto K, Hoshino T.
Eur J Radiol, Mar. 2015 - COPD assessment tests scores are associated with exacerbated chronic obstructive pulmonary disease in Japanese patients.
Suetomo M, Kawayama T, Kinoshita T, Takenaka S, Matsuoka M, Matsunaga K, Hoshino T.
Respir Investig, Sep. 2014 - Exhaled nitric oxide measurement may predict asthma exacerbation after stepping down formoterol/budesonide combination therapy in adult asthma.
Shirai T, Kawayama T, Nagase H, Inoue H, Sato S, Asano K, Kume H.
J Allergy Ther, May 2014 - Natural regulatory T cells in isolated early responders compared with dual responders with allergic asthma.
Kinoshita T, Baatjes A, Smith SG, Dua B, Watson R, Kawayama T, Larche M, Gauvreau GM, O'Byrne PM.
J Allergy Clin Immunol, Mar. 2014 - The progression of comorbidity in IL-18 transgenic chronic obstructive pulmonary disease mice model.
Takenaka S, Kawayama T, Imaoka H, Sakazaki Y, Oda H, Kaku Y, Matsuoka M, Okamoto M, Kato S, Yamada K, Hoshino T.
Biochem Biophys Res Commun, Mar. 2014 - Overexpression of CD163, CD204 and CD206 on alveolar macrophages in the lungs of patients with severe chronic obstructive pulmonary disease.
Kaku Y, Imaoka H, Morimatsu Y, Komohara Y, Ohnishi K, Oda H, Takenaka S, Matsuoka M, Kawayama T, Takeya M, Hoshino T.
PLoS One, Jan. 2014 - Interleukin-18 expression, CD8(+) T cells, and eosinophils in lungs of nonsmokers with fatal asthma.
Oda H, Kawayama T, Imaoka H, Sakazaki Y, Kaku Y, Okamoto M, Kitasato Y, Edakuni N, Takenaka S, Yoshida M, Iwanaga T, Kato S, O'Byrne PM, Hoshino T.
Ann Allergy Asthma Immunol, Jan. 2014 - Increased serum levels of soluble IL-18 receptor complex in patients with allergic asthma.
Imaoka H, Takenaka S, Kawayama T, Oda H, Kaku Y, Matsuoka M, Sakazaki Y, O'Byrne PM, Hoshino T.
Allergol Int, Dec. 2013 - Prognostic value of EGFR mutation and ERCC1 in patients with non-small cell lung cancer undergoing platinum-based chemotherapy.
Yamashita F, Azuma K, Yoshida T, Yamada K, Kawahara A, Hattori S, Takeoka H, Zaizen Y, Kawayama T, Kage M, Hoshino T.
PLoS One, Aug. 2013 - Decreased CTLA4+ and Foxp3+ CD25highCD4+ Cells in Induced Sputum from Patients with Mild Atopic Asthma.
Kawayama T, Matsunaga K, Kaku Y, Yamaguchi K, Kinoshita T, O'Byrne PM, Hoshino T.
Allergol Int, Jun. 2013 - Positive association between the plasma levels of 5-hydroxyindoleacetic acid and the severity of depression in patients with chronic obstructive pulmonary disease.
Sekiduka-Kumano T, Kawayama T, Ito K, Shoji Y, Matsunaga K, Okamoto M, Edakuni N, Imaoka H, Uchimura N, Hoshino T.
BMC Psychiatry, May 2013 - Successful treatment with tacrolimus in a case of lung-dominant connective tissue disease.
Okamoto M, Fujimoto K, Nakamura M, Yoshida T, Idemoto A, Kitasato Y, Kawayama T, Fukuoka J, Ichiki M, Hoshino T.
Intern Med, Mar. 2013 - IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13.
Sawada M, Kawayama T, Imaoka H, Sakazaki Y, Oda H, Takenaka S, Kaku Y, Azuma K, Tajiri M, Edakuni N, Okamoto M, Kato S, Hoshino T.
PLoS One, Jan. 2013 - Interleukin-18 in pulmonary inflammatory diseases.
Kawayama T, Okamoto M, Imaoka H, Kato S, Young HA, Hoshino T.
J Interferon Cytokine Res., Oct. 2012 - Depression, but not sleep disorder, is an independent factor affecting exacerbations and hospitalization in patients with chronic obstructive pulmonary disease.
Ito K, Kawayama T, Shoji Y, Fukushima N, Matsunaga K, Edakuni N, Uchimura N, Hoshino T.
Respirology., Aug. 2012 - Development of the Japanese version of the COPD Assessment Test.
Tsuda T, Suematsu R, Kamohara K, Kurose M, Arakawa I, Tomioka R, Kawayama T, Hoshino T, Aizawa H.
Respir Investig., Jun. 2012 - Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics.
Matsunaga K, Yanagisawa S, Hirano T, Ichikawa T, Koarai A, Akamatsu K, Sugiura H, Minakata Y, Matsunaga K, Kawayama T, Ichinose M.
Clin Exp Allergy, May 2012 - Overexpression of chitinase 3-like 1/YKL-40 in lung-specific IL-18-transgenic mice, smokers and COPD.
Sakazaki Y, Hoshino T, Takei S, Sawada M, Oda H, Takenaka S, Imaoka H, Matsunaga K, Ota T, Abe Y, Miki I, Fujimoto K, Kawayama T, Kato S, Aizawa H.
PLoS One, Sep. 2011 - Periostin, a matrix protein, is a novel biomarker for idiopathic interstitial pneumonias.
Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Kawayama T, Fujimoto K, Ohshima K, Shiraishi H, Uchida M, Ono J, Ohta S, Kato S, Izuhara K, Aizawa H.
Eur Respir J, May 2011 - Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy.
Imamura Y, Azuma K, Kurata S, Hattori S, Sasada T, Kinoshita T, Okamoto M, Kawayama T, Kaida H, Ishibashi M, Aizawa H.
Lung Cancer, Jan. 2011 - Elevated levels of thioredoxin 1 in the lungs and sera of idiopathic pulmonary fibrosis, non-specific interstitial pneumonia and cryptogenic organizing pneumonia.
Iwata Y, Okamoto M, Hoshino T, Kitasato Y, Sakazaki Y, Tajiri M, Matsunaga K, Azuma K, Kawayama T, Kinoshita T, Imaoka H, Fujimoto K, Kato S, Yano H, Aizawa H.
Intern Med., Nov. 2010 - Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population.
Matsunaga K, Hirano T, Kawayama T, Tsuburai T, Nagase H, Aizawa H, Akiyama K, Ohta K, Ichinose M.
Allergol Int., Aug. 2010 - Endogenous and Exogenous Thioredoxin 1 Prevents Goblet Cell Hyperplasia in a Chronic Antigen Exposure Asthma Model.
Imaoka H, Hoshino T, Okamoto M, Sakazaki Y, Sawada M, Takei S, Kinoshita T, Kawayama T, Kato S, Aizawa H.
Allegrology International, Jun. 2009 - Validation of "lung age" measured by spirometry and handy electronic FEV1/FEV6 meter in pulmonary diseases.
Toda R, Hoshino T, Kawayama T, Imaoka H, Sakazaki Y, Tsuda T, Takada S, Kinoshita M, Iwanaga T, Aizawa H.
Internal Medicine, Apr. 2009 - High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or Cor pulmonale
Inoue Y, Kawayama T, Iwanaga T, Aizawa H.
Internal Medicine, Apr. 2009 - Validation of symptom-based COPD questionnaires in Japanese subjects
Kawayama T, Minakata Y, Matsunaga K, Yamagata T, Tsuda T, Kinoshita M, Iwanaga T, Ichinose M, Aizawa H.
Respirology, May 2008 - Effect of add-on therapy of tiotropium in COPD treated with theophylline
Kawayama T, Hoshino T, Ichiki M, Tsuda T, Kinoshita M, Takata S, Koga T, Iwanaga T, Aizawa H; Kurume COPD Study Group.
Int J Chron Obstruct Pulmon Dis, Mar. 2008 - Clinical efficacy of the transdermal tulobuterol patch in patients with chronic obstructive pulmonary disease: a comparison with slow-release theophylline
Minami S, Kawayama T, Ichiki M, Nishiyama M, Sueyasu Y, Gohara R, Kinoshita M, Koga H, Iwanaga T, Aizawa H.
Intern Med, Mar. 2008 - Interleukin-18 production and pulmonary function in COPD
Imaoka H, Hoshino T, Takei S, Kinoshita T, Okamoto M, Kawayama T, Kato S, Iwasaki H, Watanabe K, Aizawa H.
Eur Respir J, Feb. 2008 - Thioredoxin prevents the development and progression of elastase-induced emphysema
Kinoshita T,Hoshino T,Imaoka H,Ichiki H,Okamoto M,Kawayama T,Yodoi J,Kato S,Aizawa H
Biochem Biophys Res Commun, Mar. 2007 - Effects of thioredoxin on established airway remodeling in a chronic antigen exposure asthma model
Imaoka H,Hoshino T,Takeki S,Sakazaki Y,Kinoshita T,Okamoto M,Kwayama T,Yodoi J,Kato S,Iwanaga T,Aizawa H
Biochemical and Biophysical Research Communications, 2007 - Pulmonary Inflammation and Emphysema:Role of Cytokines IL-18 and IL-13
Hoshino T,Kato S,Oka N,Imaoka H,Kinoshita T,Takei S,Kitasato Y,Kawayama T,Imaizumi T,Yamada K,Young HA,Aizawa H
Am J Respir Crit Care Med, 2007 - The risk factors for mortality of community-acquired pneumonia in Japan
Fujiki R,Kawayama T,Ueyama T,Ichiki M,Aizawa H
J Infect Chemother, 2007
- COPDの薬物療法
川山智隆
大川三潴医師会誌, 2011 - COPDの新しいQOL評価法 ーCAT-
川山智隆 竹中慎一 相澤久道
Medical Practice, 2011 - 気管支喘息の病態とその治療の選択
川山智隆
大牟田内科小児科医会報, Jan. 2011 - 気管支喘息の最近の話題
川山智隆
伊万里・有田地区三師会学術講演会, Dec. 2007 - COPDの診断と治療 ―チオトロピウムを中心に―
川山智隆
徳山医師会講演会, Nov. 2007 - 気管支喘息の最近の話題
川山智隆
大牟田医師会学術講演会, Oct. 2007 - 気管支喘息の最近の話題
川山智隆
大川三潴内科小児科医師会学術講演会, Sep. 2007 - 21世紀の生活習慣病～COPDをどう診察しどう治療するか?
川山智隆
筑前地区勉強会, Sep. 2007 - 気管支喘息の最近の話題
川山智隆
小郡・三井医師会学術講演会, Sep. 2007 - 気管支喘息におけるロイコトリエン拮抗薬の位置づけ
川山智隆
田川医師会学術講演会, Sep. 2007 - 21世紀の生活習慣病～COPDをどう診察しどう治療するか?
川山智隆
筑後市勉強会, Sep. 2007 - 21世紀の生活習慣病～COPDをどう診察しどう治療するか?
川山智隆
三井・小郡COPD研究会, Sep. 2007 - 気管支喘息の最近の話題
川山智隆
柳川山門医師会学術講演会, Aug. 2007 - 気管支喘息における最新治療戦略とその効果判定について
川山智隆
唐津東松浦郡呼吸器疾患学術講演会, May 2007 - COPDの診断と治療「チオトロピウムを中心に」
川山智隆
田川医師会・田川薬剤師会学術講演会, Mar. 2007 - 胸部X線写真 -緊急呼吸器疾患と見逃しやすい呼吸器疾患の見方-
川山智隆、岡元昌樹、相澤久道
呼吸と循環, 2007 - COPDの急性増悪の原因
川山智隆、木下隆、相澤久道
呼吸と循環, 2007 - 胸部X線写真―正常およびよくみる呼吸器疾患の見方―
川山智隆、岡元昌樹、相澤久道
呼吸と循環, 2007 - 新しくなったガイドラインの変更点-GOLDと日本呼吸器学会の比較-
川山智隆、相澤久道
THE LUNG, 2005 - Regulatory T Cell と気管支喘息
川山智隆、相澤久道
呼吸, 2005
- COPD死亡率減少に向けた日本呼吸器学会の取り組み～COMORE-By2032～
川山智隆
検査と技術, Jul. 2024 - 喘息とCOPDのオーバーラップ診断と治療の手引き[第2版] 2023
川山智隆, Joint work, 第4章 病態 気流閉塞の成因
メディカルレビュー社, 2024 - 今日の治療指針. 私はこう治療している 2024
川山智隆, 気管支拡張症
医学書院, 2024 - (二次出版)慢性閉塞性肺疾患の第一選択治療としてのLAMA/LABA―エビデンスおよびガイドラインによる推奨事項の概要―
Miravitlles M, 川山智隆、Dreher M., Contributor
Therapeutic Research, Oct. 2023 - 日本CT検診学会 夏期セミナー 第4回COPDセミナー「COPDの総論とガイドライン6版のポイント」のまとめ
川山智隆, Single work
CT検診学会誌, Oct. 2023 - Q&A 妊娠中の吸入治療で注意すべきことは?授乳婦の吸入治療で注意すべきことは?
川山智隆, Contributor
吸入療法エキスパートのためのガイドブック2023. 協和企画, Jul. 2023 - 特集 I. COPD実地診療にガイドラインをどう活かすか. COPDの安定期薬物療法
川山智隆、松永和子、藤木玲, Contributor
呼吸器ジャーナル, Aug. 2022 - 一般内科医のCOPD診療の役割. COPDの健康寿命延長を達成するためにはどうするか
川山智隆、藤木玲, Contributor
Medical Practice, Aug. 2022 - ランチョンセミナー9「COPDにおけるトリプル療法の意義」のまとめ
川山智隆, Single work
日本呼吸ケアリハ誌, Jul. 2022 - シンポジウム高齢者患者の課題. 薬物療法の問題点.
川山智隆、西山守、木下隆., Contributor
日本呼吸ケアリハ誌, Jul. 2022 - Catch Up! 診断ガイドライン① COPD診断と治療のためのガイドライン, 改訂!特集/2022年なにがあった?
川山智隆、藤木玲、外山貴之、松永和子, Contributor
薬局, Jun. 2022 - 日本呼吸器学会. COPD(慢性閉塞性肺疾患)診断と治療のガイドライン2022 第6版
柴田陽光、川山智隆、室繁郎、杉浦久敏編集, Contributor
メディカルレビュー社, Jun. 2022 - 安定期管理の新しいアルゴリズム. 特集/COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン2022を読み解く
川山智隆、松永和子、藤木玲., Contributor
呼吸器内科, 2022 - 特集/重症気管支喘息治療のアップデート. 「合併症を有する重症喘息:COPD」
川山智隆、恒吉信吾、矢野稜、松永和子、木下隆, Contributor
呼吸器内科, 2022 - 喘息の発症メカニズムと治療・管理. 「家庭での喘息症状および発作への自己管理-ICS/ホルモテロール頓用を含めて-」
川山智隆、恒吉信吾、矢野稜, Contributor
医のあゆみ, 2022 - 7-4 慢性閉塞性肺疾患(COPD)(Asthma and COPD Overlap, ACO)
川山智隆, Contributor
日本アレルギー学会編集. 喘息予防・管理ガイドライン2021, Oct. 2021 - 呼吸器疾患診療ガイドラインのMinds準拠の現状と導入に向けた取り組み
川山智隆、西村守、矢野稜, Contributor
呼吸器内科, 2021 - COPDの診療-診断の進め方
川山智隆, Contributor
月刊臨床と研究, 2021 - I 閉塞性肺疾患、気管支の異常、嚢胞瀬疾患 慢性気管支炎.
川山智隆, Contributor
呼吸器症候群(第3版)I -その他の呼吸器疾患を含めて-. 別冊日本臨床 領域別症候群シリーズ, 2021 - 日本呼吸器学会会員における大学院進学に関する最近の動向
髙橋浩一郎,小林信明,浅井一久,礒部威,今泉和良,大平徹郎,長内忍,川山智隆,國近尚美,小林和幸,佐野博幸,多賀谷悦子,千葉弘文,橋本直純,須田隆文,金子猛, Contributor
日呼吸誌, 2021 - 呼吸器内科医師の海外留学に関するアンケート調査.
小林信明,髙橋浩一郎,浅井一久,礒部威,今泉和良,大平徹郎,長内忍,川山智隆,國近尚美,小林和幸,佐野博幸,多賀谷悦子,千葉弘文,橋本直純,須田隆文,金子猛., Contributor
日呼吸誌, 2021 - 治療薬解説 3剤配合吸入薬とその適応病態
川山智隆, Contributor
Current Therapy, 2021 - C. 安定期の管理. 5. 全身併存症および肺合併症への対応.
川山智隆, Contributor
日本呼吸器学会著. COPD(慢性閉塞性肺疾患)診断と治療のためのガイドライン2018 第5版, May 2018 - 特集気管支喘息・COPD診療に強くなる. 気管支喘息・COPDの初期診断はこうすべき. 「COPDの初期診断はこうすべき」
川山智隆、木下隆、富永芳和, Contributor
Medicina, 2018 - サイトカイン・ケモカイン. 三嶋理晃、井上博雅編集 呼吸器疾患診断治療アプローチ
川山智隆、木下隆、松岡昌信, Contributor
「気管支喘息」 中山書店, Jul. 2017 - 特集/COPDの増悪を考える 【テーマ】7. COPDの増悪の薬物治療.
木下隆、井上譲、川山智隆、星野友昭, Contributor
呼吸器内科, Jun. 2017 - 特集COPDの増悪を考える. COPDの増悪の薬物治療
木下隆、井上譲、川山智隆、星野友昭, Contributor
呼吸器内科, 2017 - Asthma-COPD overlap (ACO)
木下隆、川山智隆、佐々木潤、富永芳和、星野友昭, Contributor
臨床と研究, 2017 - 気管支喘息の気道炎症をどうコントロールするか
木下 隆、田中丸真希、平岡裕樹、松永和子、星野友昭, Contributor
臨と研, Nov. 2015 - 気道炎症の評価方法
木下 隆、坂崎優樹、今村陽平、最所知佳、松永和子、星野友昭, Contributor
呼と循, Oct. 2015 - 呼気NO測定―適応と臨床的意義―
木下 隆、星野友昭, Contributor
Medicina, Sep. 2015 - 呼吸器疾患における右心不全あるいは肺性心の管理
木下 隆、田中丸真希、松永和子、星野友昭, Contributor
呼吸, Aug. 2015 - アトピー型気管支ぜん息患者における気道過敏性とアレルゲン吸入負荷試験の意義
木下 隆、最所知佳、田中丸真希、星野友昭, Contributor
アレルギーの臨, Jun. 2015 - 8-6-9 胃食道逆流症(GERD)
日本アレルギー学会喘息ガイドライン専門部会編, Contributor
喘息予防・管理ガイドライン2015, May 2015 - 8-6-8 心不全
日本アレルギー学会喘息ガイドライン専門部会編, Contributor
喘息予防・管理ガイドライン2015, May 2015 - 吸入療法
日本呼吸器学会編, Contributor
新呼吸器専門医テキスト, Apr. 2015 - 喀痰採取法と細胞診.
日本呼吸器学会編, Contributor
新呼吸器専門医テキスト, Apr. 2015 - COPDの病態理解の変遷と治療の新展開. 5. COPDと併存症.
川山智隆、木下隆、最所知佳、田中丸真希、松永和子、星野友昭., Contributor
Prog med, Feb. 2015 - 全身成人病としてのCOPD. 睡眠障害, うつ病.
川山智隆、木下隆、坂元暁、松永和子、星野友昭., Contributor
成人病と生活習慣病, Sep. 2014 - 特集/重症喘息. 治療(生物学的製剤を中心に).
木下隆、川山智隆、最所知佳、星野友昭., Contributor
アレルギーの臨, Jun. 2014 - COPDの最新情報 フェノタイプ分類と個別化医療の可能性.
川山智隆、木下 隆、松永和子、坂元暁、星野友昭., Contributor
日本呼吸器学会誌, May 2014 - COPDを改めて問う 治療:肺病変と気道病変への対策.
川山智隆、木下 隆、枝國信貴、坂元暁、松本恵太、松永和子、星野友昭., Contributor
The lung perspectives, Apr. 2014 - 気管支喘息およびCOPDの吸入療法.
川山智隆、木下 隆、田尻守拡., Contributor
日本呼吸ケア・リハビリテーション学会雑誌, Apr. 2014 - COPD治療のコントラバシー. 血液検査でCOPDの病状がわかるバイオマーカーはないのか?
川山智隆、一木裕子、木下 隆、松永和子、星野友昭., Contributor
内科, Feb. 2014 - 病態からみたCOPDの治療戦略
川山智隆, Single work
飯塚医師会報VOICE, Feb. 2014 - 病態からみたCOPD治療戦略
川山智隆, Single work
八女筑後医報, Dec. 2013 - 特集変貌する肺の生活習慣病COPD-早期診断で併存症にも影響-「COPDと全身併存症.」
木下隆、川山智隆、川野奈菜、松本恵太、松永和子、星野友昭., Contributor
Modern physician, Nov. 2013 - 古くて新しいCOPDは多種多彩な全身性併存症を保有する.
川山智隆、木下 隆、一木裕子、松永和子、星野友昭., Contributor
久留米医学会雑誌., Aug. 2013 - 特集/喘息とCOPDの合併 合併病態の治療と予後.
川山智隆、木下隆、嶋田知生、川野(内田)奈菜、松永和子、星野友昭., Contributor
アレルギーの臨床, Jul. 2013 - 特集「COPDの併存症とその治療」 うつ・睡眠障害.
川山智隆、伊藤光佑、嶋田知生、内田奈菜、松永和子、星野友昭., Contributor
呼吸器内科, Jun. 2013 - シンポジウムII COPD assessment test(CAT)を用いたCOPD管理.
川山智隆、田尻守拡、木下隆, Contributor
日本呼吸ケア・リハビリテーション学会誌, Feb. 2013 - 特集ガイドラインをふまえ、気管支喘息の病態研究・治療の最前線に迫る 「心不全合併喘息の臨床対応はどのようにおこなうか」.
川山智隆、木下隆、一木裕子、松永和子、星野友昭., Contributor
Respiratory Medical Research, Jan. 2013 - 8-6-8 胃食道逆流症 (GERD)
一般社団法人日本アレルギー学会, Contributor
喘息予防・管理ガイドライン2012, Nov. 2012 - 8-6-5 喘息と心不全
一般社団法人日本アレルギー学会, Contributor
喘息予防・管理ガイドライン2012 協和企画, Nov. 2012 - 研修医・一般医に知ってほしい呼吸器疾患診断・治療法 胸部単純X線写真
川山智隆、中川原寛子、井上譲、松永和子、星野友昭, Others
呼吸, 2012 - COPD薬物療法の新展開 疾患進行に対する薬物療法
川山智隆、三木康行、古賀智絵、松永和子、星野友昭, Others
MEDINAL, 2012 - 好酸球性肺炎(急性/慢性)
川山智隆, Single work
今日の治療指針 2011, 2011 - わが国で治験実施中のCOPD治療薬
今岡治樹 川山智隆 相澤久道, Contributor
THE LUNG perspectives, 2011 - 治療手技 気管挿管と人工呼吸管理
相澤久道編集, Contributor
臨床呼吸器内科マニュアル, Apr. 2009 - 検査 喀痰検査
相澤久道編集, Contributor
臨床呼吸器内科マニュアル 南江堂, Apr. 2009 - 検査 呼気凝縮液採取法
相澤久道編集, Contributor
臨床呼吸器内科マニュアル, Apr. 2009 - 呼吸器救急への対応 心肺蘇生
相澤久道編集, Contributor
臨床呼吸器内科マニュアル, Apr. 2009 - 閉塞性細気管支炎
山口 徹、北原光夫、福井次矢編集, Contributor
今日の治療指針2009 医学書院, Jan. 2009 - II-E. 画像診断 III-C. 長時間作用型b2刺激薬
相澤久道, Contributor
気管支喘息の診療ポイントガイド, Jul. 2008 - 基準値と各種ノモグラム
相澤久道, Contributor
臨床呼吸機能検査 第7版, Jun. 2008 - 気管支喘息とCOPDにおける抗コリン薬の位置づけ
川山智隆, Contributor
気管支喘息とCOPDの類似点・相違点 メディカルレビュー社, 2007
- Insulin resistance associated with systemic inflammation in POCD
Kawayama T,Sekizuka T,Matsunaga K,Hoshino T
American Thoracic Society international conference 2011, May 2011 - 呼吸器疾患とGERD「GERDと喘息・慢性咳嗽」
川山智隆
第51回日本呼吸器学会学術講演会, Apr. 2011 - Effects of Inhaled Fluticasone Propionate on CTLA-4 positive CD4+CD25+ Cells in Induced Sputum in Mild Asthmatics
Kawayama T1, Kinoshita T1,Imaoka H1,Gail M. Gauvreau2,Paul M. O’Byrne2, AIzawa H 1Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. 2Asthma Research Group, Department of Medicine, McMaster University, Hamilton, ON, Canada.
12th Congress of the APSR, Dec. 2007 - シンポジウム1「呼吸器感染症治療のガイドライン―up to date―」Ⅲ.「気道感染症ガイドライン」
川山智隆
第59回日本呼吸器学会九州地方会, Nov. 2007 - 「COPDの急性増悪 ―エビデンスに基く治療―」 1.急性増悪の定義,その予知,早期発見
川山智隆
第47回日本呼吸器学会学術講演会, May 2007 - Enhanced expression of IL-18 and IL-13 but not IL-4 or IFN-γ in COPD
Takei S,Hoshino T,Imaoka H,Kinoshita T,Kitasato Y,Kawayama T,Koga T,Kato S,Shirakusa T,Watanabe K,Aizawa H
American Thoracic Society of Respirology(APSR), May 2007 - 日本人を対象としたCOPD質問票の有用性についての検討
川山智隆、南方良章、松永和人、山縣俊之、津田徹、木下正治、一ノ瀬正和、相澤久道
第47回日本呼吸器学会学術講演会, May 2007 - Enhanced expression of IL-18 and IL-13 in lungs of COPD
Takei S,Imaoka H,Hoshino T,Kinoshita T,Kitasato Y,Kawayama T,Koga T,Watanabe K,Aizawa H
第47回日本呼吸器学会学術講演会, May 2007
■ Affiliated academic society
- Jan. 2005 - Present
The Japanese Society of Allergology - Sep. 2004 - Present
The Japan Society for Respiratory Care and Rehabilitation - Sep. 1991 - Present
The Japanese Respiratory Society - Jun. 1990
The Japanese Society of Internal Medicine
- Research on the role of eosinophil surface markers and its clinical application to evaluation of remission of severe asthma with nasal polyps
Grant-in-Aid for Scientific Research (C)
Kurume University
Apr. 2024 - Mar. 2027 - Basic research on eosinophil subsets to aim a precision medicine for severe eosinophilic asthma
Grant-in-Aid for Scientific Research (C)
Kurume University
Apr. 2021 - Mar. 2024 - Elucidation of mechanism and development of novel biomarkers on a perception of dyspnea with effort breathing based on multidimensional analyses
Grant-in-Aid for Scientific Research (C)
Kurume University
Apr. 2018 - Mar. 2021 - A preliminary study of identification and inhibitive mechanisms of airway regulatory B cells in chronic airway inflammatory diseases
Grant-in-Aid for Scientific Research (C)
Kurume University
Apr. 2015 - Mar. 2018 - An optimized measurement of effort breath by functional MRI
Grant-in-Aid for Young Scientists (B)
Kurume University
Apr. 2015 - Mar. 2017 - Epidemiology in patients with COPD with depression and sleep disorder and systemic biomakers in depressed COPD patients in Japan
Grant-in-Aid for Scientific Research (C)
Kurume University
2011 - 2013
■ 共同研究実績
- Shibata Y, Kawayama T, Muro S, Sugiura H; members of Japanese Respiratory Society COPD Guideline 6th Edition Editing Committee. Management goals and stable phase management of patients with chronic obstructive pulmonary disease in the Japanese respiratory society guideline for the management of chronic obstructive pulmonary disease 2022 (6th edition). Respir Investig. 2023;61(6):773-780.
- Ichikado K, Kotani T, Kondoh Y, Imanaka H, Johkoh T, Fujimoto K, Nunomiya S, Kawayama T, Sawada M, Jenkins E, Tasaka S, Hashimoto S. Clinical efficacy and safety of multipotent adult progenitor cells (invimestrocel) for acute respiratory distress syndrome (ARDS) caused by pneumonia: a randomized, open-label, standard therapy-controlled, phase 2 multicenter study (ONE-BRIDGE). Stem Cell Res Ther 2023;14(1):217.
- Tanimura K, Sato S, Fujita Y, Yamamoto Y, Hajiro T, Horita N, Kawayama T, Muro S. The efficacy and safety of additional treatment with short-acting muscarinic antagonist combined with long-acting beta-2 agonist in stable patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. Chron Respir Dis. 2023;20:14799731231166008.
- Fujiki R, Kawayama T, Furukawa K, Kinoshita T, Matsunaga K, Hoshino T. The Efficacy and Safety of First-Line Single-Inhaler Triple versus Dual Therapy in Controller-Na?ve and Symptomatic Adults with Asthma: A Preliminary Retrospective Cohort Study. J Asthma Allergy. 2023;16:227-237.
- Miravitlles M, Kawayama T, Dreher M.LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. J Clin Med. 2022 Nov 8;11(22):6623. doi: 10.3390/jcm11226623.
- Fujiki R, Kawayama T, Furukawa K, Kinoshita T, Matsunaga K, Hoshino T.Daytime and Nighttime Visual Analog Scales May Be Useful in Assessing Asthma Control Levels Before and After Treatment. J Asthma Allergy. 2022 Oct 26;15:1549-1559. doi: 10.2147/JAA.S381985.
- Tsuneyoshi S, Kawayama T, Sasaki J, Kinoshita T, Yano C, Tokunaga Y, Matsuoka M, Imaoka H, Matsunaga K, Furukawa K, Hoshino T.Poor Asthma Control in Schoolchildren May Lead to Lower Lung Function Trajectory from Childhood to Early Adulthood: A Japanese Cohort Study. J Asthma Allergy. 2022 Jun 30;15:885-896. doi: 10.2147/JAA.S366453.
- Harada Y, Tominaga M, Iitoh E, Kaieda S, Koga T, Fujimoto K, Chikasue T, Obara H, Kakuma T, Ida H, Kawayama T, Hoshino T. Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy. J Clin Med. 2022 Mar 30;11(7):1925. doi: 10.3390/jcm11071925.
- Yano C, Tominaga M, Naito Y, Tokunaga Y, Kinoshita T, Sasaki J, Okamoto M, Yaita K, Obara H, Kakuma T, Hoshino T, Kawayama T. Airway hyperresponsiveness and inflammation in Japanese patients with human immunodeficiency virus 1 infection. J Infect Chemother. 2022 Mar;28(3):426-433. doi: 10.1016/j.jiac.2021.12.001.
- Takahashi K, Tashiro H, Tajiri R, Takamori A, Uchida M, Kato G, Kurihara Y, Sadamatsu H, Kinoshita T, Yoshida M, Kawaguchi A, Kimura S, Sueoka-Aragane N, Kawayama T; Saga-na?ve COPD Physical Activity Evaluation (SCOPE) Study Investigator Group. Factors Associated with Reduction of Sedentary Time Following Tiotropium/Olodaterol Therapy in Treatment-Na?ve Chronic Obstructive Pulmonary Disease. Int J Chron Obstruct Pulmon Dis. 2021 Dec 6;16:3297-3307. doi: 10.2147/COPD.S338560.
■ 関心を持って取組んでいる活動
